Vanguard Asset Management
DAWN

Vanguard Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Vanguard Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,545
Closed -$1.08M – 2461
2026
Q1 		$1.08M Buy
+50,545
New +$712K ﹤0.01% 1757

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Asset Management's DAWN Position: Q2 2026 in Review

Vanguard Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 50,545 shares — an estimated $1.08M sold.

Vanguard Asset Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $1.08M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Vanguard Asset Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Asset Management sold 50,545 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.08M.
  • Vanguard Asset Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Asset Management's Day One Biopharmaceuticals position peaked at $1.08M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.